A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia - Concepedia

Concepedia

Publication | Open Access

A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia

DOI Full Paper Access

179

Citations

56

References

2007

Year

Donald Goff, J. Steven Lamberti, Andrew C. Leon, Michael F. Green, Alexander L. Miller, Jayendra K. Patel, Theo C. Manschreck, Oliver Freudenreich, Steve A. Johnson

Neuropsychopharmacology

PsychiatryPsychotic DisorderMedicinePsychotropic MedicationPsychopharmacologySchizophreniaNeuropharmacologyNeuropsychiatryCognitive DeficitsPlacebo-controlled Add-on TrialNeuroscienceBiological PsychiatrySocial SciencesCognitive NeurosciencePsychopathology

References

	Year	Citations

Page 1

Page 1